13967/34347US=23-E / Câncer
Mowla SJ, Jafarnejad SM, Atlasi Y. Detection of OCT-4 in bladder cancer: role of cancer stem cell. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 211-26. ISBN 978-90-481-2917-1.

DETECCAO DE OCT-4; CANCER DE BEXIGA; PAPEL DE CELULA-TRONCO DO CANCER


13968/34347US=1-A / Farmacologia
Chambers HF. Princípios gerais da terapia antimicrobiana. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 983-97. ISBN 85-6330801-6.

AGENTES ANTIMICROBIANOS


13969/34347US=1-A / Farmacologia
Petri WA Jr. Sulfonamidas, sulfametoxazol-trimetoprima, quinolonas e agentes para infecções do trato urinário. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 999-1012. ISBN 85-6330801-6.

SULFONAMIDAS; SULFONAMIDAS. PROPRIEDADES FARMACOLOGICAS; SULFAMETOXAZOL-TRIMETOPRIMA; QUINOLONA; INFECCOES DO TRATO URINARIO. TRATAMENTO


13970/34347US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 231-42. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DAS MUCINAS


13971/34347US=23-E / Câncer
Baker AC, Grizzle WE, Chhieng D. Uterine cervical glandular lesions: differentiation using immunohistochemistry of mucins. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 243-53. ISBN 978-90-481-2917-1.

CERVICO-UTERINO; LESOES GLANDULARES; IMUNOHISTOQUIMICA DE MUCINAS


13972/34347US=1-A / Farmacologia
Petri WA Jr. Penicilinas, cefalosporinas e outros antibióticos betalactâmicos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1013-38. ISBN 85-6330801-6.

ANTIBIOTICOS BETALACTAMICOS; PENICILINA; AMINOPENICILINA; CEFALOSPORINA; CARBAPENENS; INIBIDORES DA BETALACTAMASE


13973/34347US=23-E / Câncer
Kato S, Ohno T. Cancer imaging and intracavitary brachytherapy for cervical cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 257-62. ISBN 978-90-481-2917-1.

CANCER DE IMAGEM; BRAQUITERAPIA INTRACAVITARIA; CANCER CERVICAL


13974/34347US=23-E / Câncer
Greimel E. Cervical cancer: methods for assessing the quality of life. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 263-73. ISBN 978-90-481-2917-1.

CANCER DE COLO UTERINO; CANCER DE COLO UTERINO. QUALIDADE DE VIDA


13975/34347US=1-A / Farmacologia
Chambers HF. Aminoglicosídios. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1039-54. ISBN 85-6330801-6.

AMINOGLICOSIDIOS; AMINOGLICOSIDIOS. EFEITOS ADVERSOS; ESTREPTOMICINA; GENTAMICINA; TOBRAMICINA; AMICACINA; NETILMICINA; CANAMICINA; NEOMICINA


13976/34347US=23-E / Câncer
Lin LL, Grigsby PW. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1.

CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA


13977/34347US=1-A / Farmacologia
Chambers HF. Inibidores da síntese de proteínas e agentes antibacterianos diversos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1055-81. ISBN 85-6330801-6.

AGENTES MICROBIANOS; TETRACICLINA; CLORANFENICOL; ERITROMICINA; CLARITROMICINA; AZITROMICINA; CETOLIDEOS; TELITROMICINA; CLINDAMICINA; QUINUPRISTINA; DALFOPRISTINA; LINEZOLIDA; VANCOMICINA; MUPIROCINA


13978/34347US=23-E / Câncer
Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Cervical cancer: positron emission tomography and positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 275-84. ISBN 978-90-481-2917-1.

CANCER CERVICAL; TOMOGRAFIA POR EMISSAO DE POSITRONS; TOMOGRAFIA POR EMISSAO DE POSITRONS/TOMOGRAFIA COMPUTADORIZADA


13979/34347US=23-E / Câncer
Ino K, Yamatomoto E, Shibata K, Kajiyama H, Nawa A, Kikkawa F. Endometrial cancer: indoleamine 2,3-dioxygenase as a prognostic indicator. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 285-95. ISBN 978-90-481-2917-1.

CANCER DE ENDOMETRIO; 2,3-DIOXIGENASE INDOLEAMINA; INDICADOR DE PROGNOSTICO


13980/34347US=23-E / Câncer
Rübben A. Neurofibromatosis type 1-associated malignant melanoma: molecular evidence of inactivation of the NF1 gene. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 301-9. ISBN 978-90-481-2917-1.

NEUROFIBROMATOSE TIPO 1; MELANOMA MALIGNO; EVIDENCIA MOLECULAR DE INATIVACAO DO GENE NF1


13981/34347US=23-E / Câncer
Gheysens O, Mottaghy FM. Malignant melanoma: localisation and characterization using fluorodeoxyglucose-positron emission tomography/computed tomography. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 311-22. ISBN 978-90-481-2917-1.

MELANOMA MALIGNO; FLUORODESOXIGLICOSE POR EMISSAO DE POSITRONS; TOMOGRAFIA COMPUTADORIZADA


13982/34347US=1-A / Farmacologia
Petri WA Jr. Quimioterapia da tuberculose, complexo mycobacterium avium e hanseníase. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1083-102. ISBN 85-6330801-6.

TUBERCULOSE. TRATAMENTO FARMACOLOGICO; IONIAZIDA; RIFAMICINA; ESTREPTOMICINA; PIRAZINAMIDA; QUINOLONA; LINEZOLIDA; INTERFERONA-Y; ETIONAMIDA; ACIDO AMINOSSALICILICO; CICLOSSERINA; COMPLEXO MYCOBACTERIUM AVIUM. TRATAMENTO FARMACOLOGICO; RIFABUTINA; MACROLIDIOS; QUINOLONA; HANSENIASE. TRATAMENTO FARMACOLOGICO; SULFONAS; RIFAMPICINA; CLOFAZIMINA


13983/34347US=1-A / Farmacologia
Bennett JE. Agentes antimicrobianos: agentes antifúngicos. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1103-18. ISBN 85-6330801-6.

AGENTES ANTIFUNGICOS SISTEMICOS; ANFOTERICINA B; FLUCITOSINA; IMIDAZOL; TRIAZOL; CETOCONAZOL; ITRACONAZOL; FLUCONAZOL; CLOTRIMAZOL; ECONAZOL; MICONAZOL; TERCONAZOL; BUTOCONAZOL; TIOCONAZOL; OXICONAZOL; SULCONAZOL; SERTACONAZOL; CICLOPIROX OLAMINA; HALOPROGINA; TOLNAFTATO; NAFTIFINA; TERBINAFINA; BUTENAFINA; NISTATINA


13984/34347US=23-E / Câncer
Roesch A, Landthaler M, Vogt T. Malignant melanoma versus deep penetrating nevus:diagnostic and prognostic immunohistochemistry of dipeptidy1 peptidase IV (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 323-31. ISBN 978-90-481-2917-1.

MELANOMA MALIGNO; IMUNO-HISTOQUIMICA; DIPEPTIDE; PEPTIDASE IV; DIPEPTIDIL PEPTIDASE-4; DPP4


13985/34347US=1-A / Farmacologia
Hayden FG. Agentes antivirais (não-retrovirais). In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1119-44. ISBN 85-6330801-6.

AGENTES ANTIVIRAIS; AGENTES ANTI-HERPESVIRUS; ACICLOVIR; VALACICLOVIR; CIDOFOVIR; DOCOSANOL; FANCICLOVIR; PENCICLOVIR; FOMIVIRSENO; FOSCARNETE; GANCICLOVIR; VALGANCICLOVIR; IDOXURIDINA; TRIFLURIDINA; AGENTES ANTIINFLUENZA; AMANTADINA; RIMANTADINA; OSELTAMIVIR; ZANAMIVIR; AGENTES ANTI-HEPATITE; ADEFOVIR; INTERFERONA; LAMIVUDINA; RIBAVIRINA; IMIQUIMODE


13986/34347US=23-E / Câncer
Hafner C. Nonmelanoma skin cancer use of Epha1 receptor as a prognostic marker. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 333-40. ISBN 978-90-481-2917-1.

CANCER DE PELE; EPHA1 RECEPTOR


Primeira | Anterior | Próxima | Última